Number of citations 1year after publication of trial results and their relation to medicines regulatory approval

Dal-Re Rafael

首页> 外文期刊>British Journal of Clinical Pharmacology >Number of citations 1year after publication of trial results and their relation to medicines regulatory approval

【24h】

Number of citations 1year after publication of trial results and their relation to medicines regulatory approval

机译：试验结果公布后一年内被引用的次数及其与药品监管批准的关系

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Clinical Pharmacology》 |2016年第4期|共3页
作者
Dal-Re Rafael;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
入库时间 2022-08-18 09:14:12

相似文献

外文文献
中文文献
专利

1. Number of citations 1year after publication of trial results and their relation to medicines regulatory approval [J] . Dal-Re Rafael British Journal of Clinical Pharmacology . 2016,第4期

机译：试验结果公布后一年内被引用的次数及其与药品监管批准的关系
2. Number of citations 1year after publication of trial results and their relation to medicines regulatory approval [J] . Dal-Re Rafael British Journal of Clinical Pharmacology . 2016,第4期

机译：发布试验结果后1年的引文数量及其与药物监管批准的关系
3. Number of citations 1?year after publication of trial results and their relation to medicines regulatory approval [J] . Dal‐Ré Rafael British journal of clinical pharmacology . 2016,第4期

机译：发表试验结果后1年内被引用的次数及其与药品监管批准的关系
4. Detecting Emerging Research Fronts in Regenerative Medicine by Citation Network Analysis of Scientific Publications [C] . Naoki Shibata, Yuya Kajikawa, Yoshiyuki Takeda, Conference on Technology Management in the Age of Fundamental Change . 2009

机译：通过引文网络分析检测再生医学中的新出现研究前沿
5. Meta-Analysis to Identify and Evaluate Factors Associated with Regulatory Approval of Orphan Drugs (OD) to Develop an Algorithm for Predicting Regulatory Approval (Success) and to Develop a Standardized Tool to Improve Orphan Drug Portfolio Decision-Making [D] . Florent, Milky C. 2019

机译：荟萃分析，以识别和评估与孤儿药物监管批准（OD）相关的因素，以开发预测监管批准（成功）的算法，并开发标准化工具以改善孤儿药物投资组合决策
6. Number of citations 1 year after publication of trial results and their relation to medicines regulatory approval [O] . Rafael Dal‐Ré 2016

机译：发表试验结果后一年内被引用的次数及其与药品监管批准的关系
7. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis [O] . Huseyin Naci, Courtney Davis, Jelena Savović, 2019

机译：设计特征，偏见风险，以及随机对照试验的报告支持欧洲药物局的癌症药物批准，2014-16：横截面分析

Number of citations 1year after publication of trial results and their relation to medicines regulatory approval

著录项

相似文献

相关主题

期刊订阅